Prostate cancer Board decisions

The Board has granted service connection for prostate cancer due to presumed exposure to herbicide agents. However, the Veteran's claim for service connection for penile cancer is remanded as there is insufficient evidence regarding its etiology and whether it is secondary to his service-connected prostate cancer.

The Board has remanded the Veteran's claims for prostate cancer residuals, Cushing's syndrome, CAD, hypertension, and DMII due to exposure to various chemicals during service. The AOJ is directed to verify the Veteran's reported exposures and obtain VA opinions regarding the nature and etiology of his disabilities.

The Board denied service connection for atrial fibrillation, congestive heart failure, and prostate cancer. The Board found that these conditions did not have their onset during active duty service or were otherwise etiologically related to service.

The Board has remanded the cases for further development and consideration, including obtaining updated VA and private treatment records as well as any relevant Social Security Administration disability benefits records.

The Board has granted service connection for bilateral peripheral neuropathy of the lower extremities as secondary to diabetes mellitus, but denied service connection for bilateral peripheral neuropathy of the upper extremities. Service connection was also granted for erectile dysfunction and renal dysfunction as secondary to bladder cancer, and prostate cancer as a result of bladder cancer.,The Veteran's prostate cancer is considered secondary to his service-connected bladder cancer.

The Veteran's claims for service connection for diabetes, prostate cancer, and ischemic heart disease have been granted due to presumed exposure to herbicide agents during his service in Thailand. The Board found that the Veteran was exposed to herbicide agents at U-Tapao Royal Thai Air Force Base where he served.

The Veteran's claims for increased ratings and initial service connection have been remanded due to the need for additional medical examinations and records.

The Veteran's eligibility for benefits under the PCAFC is remanded due to a legal error in the initial decision, specifically related to the interpretation of 'need for supervision, protection or instruction' as defined by 38 C.F.R. § 71.15.

The Veteran's claim for service connection for prostate cancer residuals is being remanded due to a duty to assist error. Additional development, including a VA examination, is needed to determine if his prostate cancer is related to his period of service.

The Board has remanded the Veteran's claims for diabetes, asthma, prostate cancer, and PTSD as they are related to a petition to reopen previously denied service connection claims.

The Board has restored the original 100% rating for service-connected prostate cancer, finding that the reduction was improper due to insufficient evidence showing improvement in the disability.

The Board has granted service connection for lung cancer, prostate cancer, and Parkinson's Disease as due to herbicide exposure during the Veteran's service in Thailand.

The Board has decided that a bladder disorder is related to the service-connected prostate cancer and remands for further action.

The Board has determined that additional evidentiary development is necessary prior to the adjudication of the issue of entitlement to service connection for the cause of the Veteran's death. The issues of PTSD, TDIU rating, and substitution eligibility are not before the Board at this time.

The Board has remanded the Veteran's claims for hypertension, prostate cancer residuals, erectile dysfunction, and skin disease due to presumed exposure at Camp Lejeune. The claims will be reviewed with updated VA treatment records and a VA examination.

The Veteran's appeal is remanded for additional development, including obtaining outstanding private treatment records and an examination to identify the symptoms and residuals attributable to his bladder versus prostate cancers. The matter of a total disability rating based on individual unemployability due to service-connected disabilities (TDIU) has also been deferred pending further development.

The Veteran's claim for compensation under 38 U.S.C. § 1151 is remanded due to a lack of an adequate medical opinion regarding the impact of VA's failure to notify him about his high PSA levels, which may have led to a radical prostatectomy instead of non-surgical options.

The Veteran's prostate cancer and diabetes mellitus are presumed to have been caused by exposure to herbicide agents during his service in Thailand, leading to the grant of service connection for both conditions.

The Board has denied the veteran's claim for Dependency and Indemnity Compensation under 38 U.S.C. 1318 due to not meeting the statutory duration requirements for a total disability rating at the time of death. The Board also found that service connection in the cause of the Veteran's death is remanded as there was no opinion regarding the causality of his death.

The Board has restored the 100 percent evaluation for prostate cancer status post radical prostatectomy, effective from January 1, 2022.